Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: Trophic effects upon cholinergic and noncholinergic striatal neurons

Neuroscience

Volumn 72, Issue 1, 1996, Pages 63-77

  Kordower, J H ^a,b   Chen, E Y ^a   Mufson, E J ^a,b   Winn, S R ^c   Emerich, D F ^c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c CytoTherapeutics Inc   (United States)

Author keywords

choline acetyltransferase; Huntington's disease; immunoisolation; neurotrophins; plasticity; transplantation

Indexed keywords

CHOLINE ACETYLTRANSFERASE; GLUTAMATE DECARBOXYLASE; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; FIBROBLAST; HUNTINGTON CHOREA; IMMUNOCYTOCHEMISTRY; MALE; NERVE CELL PLASTICITY; NERVE GRAFT; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029986086     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00543-9     Document Type: Article

References (55)

1. Ashizawa T., Wong L.-J. C., Richards C. S., Caskey C. T. and Jankovic J. (1994) CAG repeat size and clinical presentation in Huntington's disease. Neurology 44, 1137-1143.
2. Baetge E. E., Suh Y. H. and Joh T. H. (1986) Complete nucleotide and deduced amino acid sequence o bovine phenylethanolamine N-methyltransferase: partial homology with rat tyrosine hydroxylase. Proc. natn. Acad. Sci. U.S.A. 83, 5454-5458.
3. LNTR reduces NGF binding to TrkA on PC 12 cells. Neuron 13, 203-215.
4. Cabasso I. (1980) Hollow fiber membranes. In Encyclopedia of Chemical Technology (ed. Othmer K.), Vol. 12, pp 492-517, Wiley, New York.
5. Cheng B. and Mattson M. P. (1992) Glucose deprivation elicits enurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and βFGF. Exp. Neurol. 117, 114-123.
6. Cheng B., McMahan D. G. and Mattson M. P. (1993) Modulation of calcium current, intracellular calcium levels and cell survival by glucose deprivation and growth factors in hippocampal neurons. Brain Res. 607, 275-285.
7. Conner J. M., Muir D., Varon S., Hagg T. and Manthorpe M. (1992) The localization of nerve growth factor-like immunoreactivity in the adult rat basal forebrain and hippocampal formation. J. comp. Neurol. 319, 454-462.
8. Conner J. M. and Varon S. (1992) Distribution of nerve growth factor-like immunoreactive in the adult rat brain following colchicine treatment. J. comp. Neurol. 326, 347-362.
9. Croll S. D., Wiegand S. J., Anderson K. D., Lindsay R. M. and Nawa H. (1994) Regulation of neuropeptides in adult rat forebrain by the neurotrophins BDNF and NGF. Eur. J. Neurosci. 6, 1343-1353.
10. Davies S. W. and Beardsall K. (1992) Nerve growth factor selectively prevents excitotoxin induced degeneraton of striatal cholinergic neurons. Neurosci. Lett. 140, 161-164.
11. Dechant G., Rodriguez-Tebar G. and Barde Y.-A. (1994) Neurotrophin receptors. Prog. Neurobiol. 42, 347-352.
12. Ebendal T. (1992) Function and evolution in the NGF family and its receptors. J. Neurosci. Res. 32, 461-470.
13. Emerich D. F., Hammang J. P., Baetge E. E. and Winn S. R. (1994) Implantation of polymer-encapsulated human nerve growth factor secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exp. Neurol. 130, 141-150.
14. Emerich D. F., Winn S. R., Hammang J. P., Baetge E. E. and Kordower J. H. (1994) Grafts of polymer-encapsulated cells genetically modified to forebrain neurons in non-human primates. J. comp. Neurol. 349, 148-164.
15. Engvall E. (1980) Enzyme immunoassay ELISA and EMIT. Meth. Enzym. 70, 419-439.
16. Ferrante R. J., Kowall N. W., Beal M. F., Richardson E. F. and Martin J. B. (1985) Selective sparing of a class of striatal neurons in Huntington's disease. Science 230, 561-563.
17. Ferrante R. J., Beal M. F., Kowall N. W., Richardson E. F. and Martin J. B. (1987) Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Res. 411, 162-166.
18. Frim D. M., Short M. P., Rosenberg W. S., Simpson J., Breakefield X. O. and Isacson O. (1993) Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum. J. Neurosurg. 78, 267-273.
19. Frim D. M., Yee W. M. and Isacson O. (1993) NGF reduces striatal excitotoxic neuronal loss without affecting concurrent neuronal stress. NeuroReport 4, 655-658.
20. Frim D. M., Uhler T. A., Short M. P., Ezzedine Z. D., Klagsbrun M., Breakefield X. O. and Isacson O. (1993) Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. J. Neurosci. Res. 35, 452-458.
21. Frim D. M., Wullner U., Bear M. R. and Isacson O. (1994) Implanted NGF-producing fibroblasts induce catalase and ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum. Exp. Neurol. 128, 172-180.
22. Fryer H. J. L., Davis G. E., Manthorpe M. and Varon S. (1986) Lowry protein assay using an automatic microtiter plate spectrophotometer. Anal. Biochem. 153, 262-266.
23. Gage F. H., Batchelor P., Chen K. S., Chin D., Higgins G. A., Koh S., Deputy S., Rosenberg M. B., Fischer W. and Björklund A. (1989) NGF receptor re-expression and NGF-mediated cholinergic neuronal hypertrophy in the damaged adult neostriatum Neuron 2, 1177-1184.
24. Greenamyer J. T. and Shoulson I. (1994) Huntington's disease. In Neurodegenerative Diseases (ed. Calne D.), pp. 685-704. Saunders Press, Philadelphia, PA.
25. Gusella J. F., Wexler N. S., Conneally P. M., Naylor S. L., Anderson M. A., Tanzi R. E., Young A. B., Shoulson I., Bonnilla E. and Martin J. B. (1983) A polymorphic marker genetically linked to Huntington's disease. Nature 306, 234-236.
26. Hantzopoulos P. A., Suri C., Glass D. J., Goldfarb M. P. and Yancopoulos G. D. (1994) The low affinity NGF receptor, p75, can collaborate with each to the trks to potentiate functional responses to the neurotrophins. Neuron 13, 187-201.
27. Higgins G. A., Koh S., Chen K. S. and Gage F. H. (1989) NGF induction of NGF receptor gene expression and cholinergic neuronal hypertrophy within the basal forebrain of the adult rat. Neuron 3, 247-256.
28. Holtzman D. M., Li Y., Parada L. F., Kinsman S., Chen C.-K., Valleta J. S., Zhou J., Long J. B. and Mobley W. C. (1992) p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF. Neuron 9, 465-478.
29. Hoyle G. W., Mercer E. H., Palmiter R. D. and Brinster R. L. (1993) Expression of NGF in sympathetic neurons leads to excessive axon outgrowth from ganglia but decreased terminal innervation within tissues. Neuron 10, 1019-1034.
30. Hsu S. M., Raine L. and Fanger H. (1981) Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577-580.
31. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-978.
32. TRKA kinase activity, but not ligand internalization, in PC12 cells. J. Neurosci. Res. 38, 599-606.
33. Kordower J. H. and Mufson E. J. (1993) NGF receptor-immunoreactivity in the developing human basal ganglia. J. comp. Neurol. 327, 359-374.
34. Kordower J. H., Charles V., Bayer R., Bartus R. T., Putney S., Walus L. and Friden P. (1994) Intravenous administration of an NGF conjugate prevents neuronal degeneration in a model of Huntington's disease. Proc. natn. Acad. Sci. U.S.A. 19, 9077-9080.
35. Kordower J. H., Winn S. R., Liu Y.-T, Mufson E. J., Sladek J. R., Hammang J. P., Baetge E. E. and Emerich D. F. (1994) The aged monkey basal forebrain: rescue and sprouting of degenerating cholinergic neurons following grafts of polymer encapsulated human NGF secreting cells. Proc. natn. Acad. Sci. U.S.A. 91, 10,898-10,902.
36. Kordower J. H., Chen E.-Y., Sladek Jr J. R. and Mufson E. J. (1994) Trk-immunoreactivity in the monkey central nervous system I - Forebrain. J. comp. Neurol. 349, 20-35.
37. Kordower J. H., Liu Y.-T., Winn S. and Emerich D. F. (1995) Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: a behavioral, neuroanatomical and neurochemical analysis. Cell Transplantation. 4, 155-171.
38. Kowall N. W., Ferrante R. J. and Martin J. (1987) Pattern of cell loss in Huntington's disease. Trends Neurosci. 10, 24-29.
39. Levi-Montalchini R. and Angeletti P. U. (1968) Nerve growth factor. Physiol. Rev. 8, 534-569.
40. Martinez H. J., Dreyfus C. F., Jonakait G. and Black I. B. (1985) Nerve growth factor promotes cholinergic development in brain striatal cultures. Proc. natn. Acad. Sci. U.S.A. 82, 7777-7781.
41. Mattson M. P., Barger S. W., Begley J. G. and Mark R. J. (1985) Calcium, free radicals, and excitotoxic neuronal death in primary cell culture Meth. Cell Biol. 46, 187-216.
42. Mattson M. P., Cheng B. and Smith-Swintosky V. L. (1993) Mechanisms of neurotrophic protection against calcium-and free radical-mediated excitotoxic injury: implications from treating neurodegenerative disorders. Exp. Neurol. 124, 89-95.
43. Mattson M. P. and Cheng B. (1993) Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis. Stroke 24, 136-140.
44. Mattson M. P. and Scheff S. W. (1994) Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. J. Neurotrauma 11, 3-33.
45. Miller F. D., Speelman A., Mathew T. C., Fabian J., Chang E., Pozniak C. and Toma J. G. (1994) Nerve growth factor derived from terminals selectively increases the ratio of p75 to trkA NGF receptors on mature sympathetic neurons. Devl Biol. 161, 206-217.
46. Mobley W. C., Rutkowski J. L., Tennekoon G. I., Buchanan K. and Johnston M. V. (1985) Choline acetyltransferase in striatum of neonatal rats increased by nerve growth factor. Science 229, 282-284.
47. Mufson E. J., Conner J. M., Varon S. and Kordower J. H. (1994) Nerve growth factor immunoreactive profiles in the primate basal forebrain and hippocampal formation. J. comp. Neurol. 341, 507-519.
48. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, pp. 1-236. Academic Press, San Diego, CA.
49. Schumacher J. M., Short M. P., Hyman B. T., Breakefield X. O. and Isacson O. (1991) Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids. Neuroscience 45, 561-570.
50. Sobreviela T., Clary D. O., Reichardt L. F., Brandabur M. M., Kordower J. H. and Mufson E. J. (1994) TrkA immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J. comp. Neurol. 350, 587-611.
51. Steininger T. L., Wainer B. H., Klein R., Barbacid M. and Palfrey H. C. (1993) High-affinity nerve growth factor receptor (Trk) immunoreactivity is localized in cholinergic neurons of the basal forebrain and striatum in the adult rat brain. Brain Res. 612, 330-335.
52. Varon S., Nomura J., Perez-Polo J. R. and Shooter E. M. (1972) The isolation and assay of the Nerve Growth Factor proteins. In Methods and Techniques of Neuroscience. (ed. Fried R.), pp. 203-229. Dekker, New York.
53. Venero J. L., Beck K. D. and Hefti F. (1994) Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger RNA, but not glutamate decarboxylase messenger RNA. Neuroscience 61, 257-268.
54. Winn S. R., Hammang J. P., Emerich D. F., Lee A., Palmiter R. D. and Baetge E. E. (1994) Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc. natn. Acad. Sci. U.S.A. 91, 23-28.
55. Yan Q. and Johnson E. M. (1988) An immunohistochemical study of the nerve growth factor receptor in developing rats. J. Neurosci. 8, 3481-3498.